1. Can trifluoperazine protect mitochondria against reactive oxygen species-induced damage?

   • R. De Souza Pereira
   • M. Hermes-Lima

   OriginalPaper Pages: 281 - 284

2. Pharmacokinetic-pharmacodynamic modelling of DP-1904, a novel thromboxane synthetase inhibitor in rabbits, based on an indirect response model

   • N. X. Zheng
   • H. Sato
   • I. Horikoshi

   OriginalPaper Pages: 285 - 293

3. Bioavailability study of paracetamol tablets in saliva and urine

   • P. Retaco
   • M. González
   • M. G. Volonté

   OriginalPaper Pages: 295 - 300

4. Dextromethorphan metabolism in Jordanians: Dissociation of dextromethorphan O-demethylation from debrisoquine 4-hydroxylation

   • Y. M. Irshaid
   • H. F. Al-Hadidi
   • N. M. Rawashdeh

   OriginalPaper Pages: 301 - 307

5. Metabolic ratios of four probes of CYP2D6 in Turkish subjects: A cross-over study

   • A. Bozkurt
   • N. E. Başçi
   • S. O. Kayaalp

   OriginalPaper Pages: 309 - 314

6. Comparative study of the biotransformation of bepridil analogs in isolated liver cells from one rat. Relationships between structure and in vitro liver toxicity

   • E. Damatte
   • M. J. Galmier
   • J. L. Chabard

   OriginalPaper Pages: 315 - 325

7. The effect of furazolidone and furaltadone on drug metabolism in rats

   • B. H. Ali
   • M. O. M. Tanira
   • A. K. Bashir

   OriginalPaper Pages: 327 - 332

8. Comparative pharmacokinetics of Aspegic 1000 mg i.v. versus 1000 mg i.m. thrice daily

   • B. Nia
   • J. M. Vergnaud

   OriginalPaper Pages: 333 - 338

9. Metabolism of 6-chloro n-butyl phthalide in rat

   • S. H. Peng
   • T. H. Zhou

   OriginalPaper Pages: 339 - 344

10. Disposition of³H-labelled buserelin continuously infused into rats

    • N. Heinrich
    • E. Albrecht
    • H. Berger

    OriginalPaper Pages: 345 - 350

11. Absence of rebound effect with calcium carbonate

    • G. Simoneau

    OriginalPaper Pages: 351 - 357

12. Events

    Announcement Pages: 359 - 360